- Home
- MGRX
MGRX
Mangoceuticals Inc.
as 11-15-2024 4:00pm EST
Mangoceuticals Inc focuses on developing, marketing, and selling a variety of men's wellness products and services through a telemedicine platform. The platform provides access for customers to a licensed pharmacy for online fulfillment and distribution of certain medications that may be prescribed as part of telehealth consultations, including Mango ED products.
| Founded: | 2021 | Country: | United States |
| Employees: | N/A | City: | DALLAS |
| Market Cap: | 5.8M | IPO Year: | 2023 |
| Target Price: | N/A | AVG Volume (30 days): | 174.3K |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -5.66 | EPS Growth: | N/A |
| 52 Week Low/High: | $2.10 - $16.80 | Next Earning Date: | 11-26-2024 |
| Revenue: | $755,000 | Revenue Growth: | 52.20% |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Latest Mangoceuticals Inc. News
MGRX Breaking Stock News: Dive into MGRX Ticker-Specific Updates for Smart Investing
GlobeNewswire
18 days ago
Mangoceuticals, Inc. Regains Full Compliance with Nasdaq Minimum Bid Price Requirement
GlobeNewswire
a month ago
MangoRx Announces Formation of Strategy and Alternatives Committee
GlobeNewswire
a month ago
MangoRx Responds to and Refutes Recent Claims Made by Eli Lilly
Newsfile
a month ago
Mangoceuticals, Inc. Announces Participation at the Centurion One Capital 2nd Annual Bahamas Summit 2024
TipRanks
a month ago
Mangoceuticals announces 1-for-15 reverse stock split
GlobeNewswire
a month ago
MANGOCEUTICALS, INC. ANNOUNCES 1-FOR 15 REVERSE STOCK SPLIT AS PART OF NASDAQ COMPLIANCE PLAN
GlobeNewswire
a month ago
MangoRx Introduces Oral Tirzepatide GLP-1 Receptor Agonist for Advanced Weight Loss Solutions
GlobeNewswire
2 months ago
MangoRx Addresses $49.3 Billion Global GLP-1 Market With Launch of Oral Semaglutide for Advanced Weight Loss Treatment
Compare MGRX vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "MGRX Mangoceuticals Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.